PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.\', \'Department of Clinical Immunology, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK.\', \'Department of Rheumatology, The Royal Wolverhampton NHS Trust, Wolverhampton, UK.\', \'Department of Haematology, Worcestershire Acute NHS Trust, Worcester, UK.\', \'Department of Haematology, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK.\', \'Department of Haematology, The Royal Wolverhampton NHS Trust, Wolverhampton, UK.\', \'Faculty of Science & Engineering, University of Wolverhampton, Wolverhampton, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1093/cei/uxab018
?:hasPublicationType
?:journal
  • Clinical and experimental immunology
is ?:pmid of
?:pmid
?:pmid
  • 35020852
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.431
?:rankingScore_hIndex
  • 121
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 vaccine responses following CD20-depletion treatment in patients with haematological and rheumatological disease: a West Midlands Research Consortium study.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all